Biological Sample Cryopreservation Industry Research Report 2026

Biological Sample Cryopreservation encompasses the controlled freezing, vitrification, and cryogenic storage technologies used to preserve living cells, tissues, reproductive materials, microorganisms, and temperature sensitive biological specimens for subsequent recovery, analysis, or biological use. The underlying preservation mechanism involves reducing molecular mobility, enzymatic activity, and biochemical degradation at ultralow temperatures while limiting structural and functional damage associated with ice crystallization, osmotic imbalance, solute concentration, and membrane disruption. Conventional slow freezing applies controlled cooling rates to promote extracellular ice formation and cellular dehydration while reducing intracellular ice formation. Vitrification uses higher cryoprotectant concentrations and rapid temperature transitions to produce an amorphous solid state with minimal ice crystallization. Cryoprotective formulations incorporate permeating agents such as dimethyl sulfoxide, glycerol, and ethylene glycol, together with nonpermeating sugars, buffering systems, and other formulation components selected according to sample characteristics and freezing methods. Preservation performance depends on the interaction between cooling rate, cryoprotectant composition, sample volume, thermal history, storage temperature, and subsequent warming conditions.
Commercial cryopreservation technologies include programmable controlled rate freezers, mechanical ultralow temperature and cryogenic freezers, liquid nitrogen storage systems, automated cryogenic sample repositories, and specialized cryopreservation media. Equipment configurations incorporate cascade refrigeration circuits, liquid nitrogen cooling and distribution assemblies, vacuum insulated stainless steel vessels, thermal control systems, and automated sample handling mechanisms. Mechanical freezers operating near minus 80°C accommodate biological materials with compatible storage requirements, while systems operating near minus 150°C and liquid nitrogen environments approaching minus 196°C are used for extended preservation of viable cellular specimens. Cryogenic storage may employ liquid phase or nitrogen vapor phase configurations, with storage architecture determined by sample characteristics, thermal stability requirements, and contamination considerations. Commercial applications encompass biological sample repositories, biomedical research, biopharmaceutical cell banking and manufacturing, cell and gene therapy, assisted reproduction, clinical specimen preservation, and animal breeding. The product market covers dedicated freezing and cryogenic storage equipment and formulated cryopreservation media used directly in biological preservation. Independent storage and logistics services, general laboratory refrigeration, standalone sample packaging consumables, and unrelated laboratory equipment fall outside the product revenue boundary.
Product & engineering
Understand the product.
Biological Sample Cryopreservation encompasses the controlled freezing, vitrification, and cryogenic storage technologies used to preserve living cells, tissues, reproductive materials, microorganisms, and temperature sensitive biological specimens for subsequent recovery, analysis, or biological use. The underlying preservation mechanism involves reducing molecular mobility, enzymatic activity, and biochemical degradation at ultralow temperatures while limiting structural and functional damage associated with ice crystallization, osmotic imbalance, solute concentration, and membrane disruption. Conventional slow freezing applies controlled cooling rates to promote extracellular ice formation and cellular dehydration while reducing intracellular ice formation. Vitrification uses higher cryoprotectant concentrations and rapid temperature transitions to produce an amorphous solid state with minimal ice crystallization. Cryoprotective formulations incorporate permeating agents such as dimethyl sulfoxide, glycerol, and ethylene glycol, together with nonpermeating sugars, buffering systems, and other formulation components selected according to sample characteristics and freezing methods. Preservation performance depends on the interaction between cooling rate, cryoprotectant composition, sample volume, thermal history, storage temperature, and subsequent warming conditions.
Commercial cryopreservation technologies include programmable controlled rate freezers, mechanical ultralow temperature and cryogenic freezers, liquid nitrogen storage systems, automated cryogenic sample repositories, and specialized cryopreservation media. Equipment configurations incorporate cascade refrigeration circuits, liquid nitrogen cooling and distribution assemblies, vacuum insulated stainless steel vessels, thermal control systems, and automated sample handling mechanisms. Mechanical freezers operating near minus 80°C accommodate biological materials with compatible storage requirements, while systems operating near minus 150°C and liquid nitrogen environments approaching minus 196°C are used for extended preservation of viable cellular specimens. Cryogenic storage may employ liquid phase or nitrogen vapor phase configurations, with storage architecture determined by sample characteristics, thermal stability requirements, and contamination considerations. Commercial applications encompass biological sample repositories, biomedical research, biopharmaceutical cell banking and manufacturing, cell and gene therapy, assisted reproduction, clinical specimen preservation, and animal breeding. The product market covers dedicated freezing and cryogenic storage equipment and formulated cryopreservation media used directly in biological preservation. Independent storage and logistics services, general laboratory refrigeration, standalone sample packaging consumables, and unrelated laboratory equipment fall outside the product revenue boundary.
Selected research
Industry Research
Biological Sample Cryopreservation Industry Research Report 2026
MARKET AT A GLANCE
Scale & outlook
- 2024
- ≈ 860USD million
- 2032
- 3,057.45USD million
Select a bar to inspect its value.
Source: APO Research, Inc.
Market perspective
According to APO Research, Inc, the global Biological Sample Cryopreservation market was valued at approximately USD 1,812.4 million in 2025 and is projected to reach USD 1,933.15 million in 2026 and USD 3,057.45 million by 2032, representing a compound annual growth rate (CAGR) of 7.94% from 2026 to 2032. Market revenue comprises dedicated controlled rate freezing equipment, ultralow temperature and cryogenic storage systems, automated biological sample repositories, and commercial cryopreservation media. Growth is driven by expanding biological specimen inventories, increased production of cell based therapeutics, and replacement of aging laboratory storage equipment. Equipment revenue depends on new installations, replacement cycles, and average selling prices, while cryopreservation media consumption follows the number of biological samples and cell manufacturing batches processed. Automated liquid nitrogen storage systems increase equipment expenditure per installation where sample capacity, retrieval frequency, and handling requirements justify additional capital investment.
Ultralow temperature freezers represent an established component of biological sample storage infrastructure. PHC Group estimated the global ultralow temperature freezer market at approximately USD 860 million in 2024 and identified emerging replacement demand for energy efficient equipment among pharmaceutical manufacturers and contract development and manufacturing organizations. Research institutions and biobanks face similar requirements as existing freezer fleets age and electricity consumption becomes a larger component of operating expenditure. In China, Haier Biomedical manufactures ultralow temperature storage equipment in Qingdao and intelligent liquid nitrogen storage systems in Chengdu, providing domestic manufacturing capacity across conventional and cryogenic storage technologies. Equipment demand in China and other Asian markets is influenced by biological sample repository development, pharmaceutical manufacturing investment, and the adoption of automated storage systems. North America, Europe, and Japan additionally generate replacement demand from established laboratory and biopharmaceutical infrastructure. Conventional freezer pricing remains subject to manufacturer competition, while automated cryogenic installations carry higher equipment values associated with insulated storage vessels, robotic handling, monitoring, and temperature management systems.
Cryogenic storage equipment and specialized preservation media are also influenced by the commercialization of advanced therapies and reproductive technologies. Cryoport reported USD 79.68 million in Life Sciences Products revenue in 2025, an increase of 6.6%, with stronger product demand in Europe, the Middle East, Africa, and Asia Pacific, alongside animal health applications in the Americas. Its product revenue includes cryogenic storage and transport equipment, reflecting demand from biological repositories, reproductive material preservation, and commercial cell therapy supply chains. BioLife Solutions reported USD 96.2 million in 2025 revenue, with biopreservation media accounting for approximately 87% of its business, including cryogenic freezing and hypothermic preservation formulations. Repligen completed its acquisition of BioLife Solutions in October 2026, adding the CryoStor cryopreservation media family to its bioprocessing business. As cell therapies advance from clinical development into commercial manufacturing, repeated production batches and frozen cellular inventories increase consumption of qualified freezing formulations. Cryoprotectant composition, post thaw cell recovery, and manufacturing process compatibility influence product selection and limit rapid substitution of established formulations. The market outlook consequently reflects continued equipment installations and replacements, a rising contribution from automated cryogenic storage, and recurring preservation media purchases tied to biological manufacturing activity.
Full market overview
Report Scope
This report quantifies the global Biological Sample Cryopreservation market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biological Sample Cryopreservation.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biological Sample Cryopreservation Market by Company
- Thermo Fisher Scientific
- Haier Biomedical
- PHCbi
- Repligen
- Cryoport
- Azenta Life Sciences
- Cytiva
- Sartorius
- FUJIFILM Biosciences
- Lonza
- Corning
- Eppendorf
- Greiner
- SARSTEDT
- Terumo
- CooperSurgical
- Vitrolife
- Nexpring Health
- Macopharma
- Miltenyi Biotec
- STEMCELL Technologies
- Kitazato
- Zhongke Meiling Cryogenics
- AUCMA
- BIOBASE
- Genepoint Technologies
- Origincell Biological Cryo Equipment
- Basecare Medical
- Hamilton Company
- LiCONiC
- ASKION
- SPT Labtech
- B Medical Systems
- Custom Biogenic Systems
- IC Biomedical
- Cryo Bio System
- Stirling Ultracold
- Helmer Scientific
- Micronic
- OriGen Biomedical
- BINDER
- Liebherr
- Esco Lifesciences
- Cryopal
- Cryotherm
- Cryo Diffusion
- Statebourne Cryogenics
- Celltrio
- ThermoGenesis
- Jiangsu SERLNG
- SYLAB
- Consarctic
- PromoCell
- FertiPro
- CryoLogic
- Cryofab
Biological Sample Cryopreservation Segment by Type
- Cryopreservation Equipment
- Cryopreservation Media & Reagents
- Cryopreservation Containers & Accessories
- Cryopreservation Services
Biological Sample Cryopreservation Segment by Application
- Biobanking
- Biomedical Research
- Biopharmaceutical Manufacturing
- Cell & Gene Therapy
- Assisted Reproduction
- Clinical Diagnostics
- Animal Breeding
Biological Sample Cryopreservation Segment by Region
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Russia
- Netherlands
- Nordic Countries
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Southeast Asia
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Middle East & Africa
- Saudi Arabia
- Israel
- United Arab Emirates
- Turkey
- Iran
- Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
- This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biological Sample Cryopreservation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
- This report will help stakeholders to understand the global industry status and trends of Biological Sample Cryopreservation and provides them with information on key market drivers, restraints, challenges, and opportunities.
- This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
- This report stays updated with novel technology integration, features, and the latest developments in the market
- This report helps stakeholders to gain insights into which regions to target globally
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biological Sample Cryopreservation.
- This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
- Chapter 1: Research objectives, research methods, data sources, data cross-validation;
- Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
- Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
- Chapter 6: Detailed analysis of Biological Sample Cryopreservation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapters 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
- Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
- Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- Table 5. Global Biological Sample Cryopreservation Market Size by Type (2021-2026) & (US$ Million)
- Table 6. Global Biological Sample Cryopreservation Revenue Market Share by Type (2021-2026)
- Table 7. Global Biological Sample Cryopreservation Forecasted Market Size by Type (2027-2032) & (US$ Million)
- Table 8. Global Biological Sample Cryopreservation Revenue Market Share by Type (2027-2032)
- Table 9. Global Biological Sample Cryopreservation Market Size by Application (2021-2026) & (US$ Million)
- Table 10. Global Biological Sample Cryopreservation Revenue Market Share by Application (2021-2026)
- Table 11. Global Biological Sample Cryopreservation Forecasted Market Size by Application (2027-2032) & (US$ Million)
- Table 12. Global Biological Sample Cryopreservation Revenue Market Share by Application (2027-2032)
- Table 13. Global Biological Sample Cryopreservation Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
- Table 14. Global Biological Sample Cryopreservation Market Size by Region (2021-2026) & (US$ Million)
- Table 15. Global Biological Sample Cryopreservation Market Share by Region (2021-2026)
- Table 16. Global Biological Sample Cryopreservation Forecasted Market Size by Region (2027-2032) & (US$ Million)
- Table 17. Global Biological Sample Cryopreservation Market Share by Region (2027-2032)
- Table 18. Biological Sample Cryopreservation Industry Trends
- Table 19. Biological Sample Cryopreservation Industry Drivers
- Table 20. Biological Sample Cryopreservation Industry Opportunities and Challenges
- Table 21. Biological Sample Cryopreservation Market Restraints
- Table 22. Global Top Biological Sample Cryopreservation Players by Revenue (US$ Million) & (2021-2026)
- Table 23. Global Biological Sample Cryopreservation Revenue Market Share by Players (2021-2026)
- Table 24. Global Biological Sample Cryopreservation Industry Players Ranking, 2024 VS 2025 VS 2026
- Table 25. Global Key Players of Biological Sample Cryopreservation, Headquarters and Area Served
- Table 26. Global Biological Sample Cryopreservation Players, Product Type & Application
- Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
- Table 28. Global Biological Sample Cryopreservation by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
- Table 29. Players Mergers & Acquisitions, Expansion Plans
- Table 30. North America Biological Sample Cryopreservation Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
- Table 31. North America Biological Sample Cryopreservation Market Size by Country (2021-2026) & (US$ Million)
- Table 32. North America Biological Sample Cryopreservation Market Size by Country (2027-2032) & (US$ Million)
- Table 33. Europe Biological Sample Cryopreservation Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
- Table 34. Europe Biological Sample Cryopreservation Market Size by Country (2021-2026) & (US$ Million)
- Table 35. Europe Biological Sample Cryopreservation Market Size by Country (2027-2032) & (US$ Million)
- Table 36. Asia Pacific Biological Sample Cryopreservation Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
- Table 37. Asia Pacific Biological Sample Cryopreservation Market Size by Region (2021-2026) & (US$ Million)
- Table 38. Asia Pacific Biological Sample Cryopreservation Market Size by Country (2027-2032) & (US$ Million)
- Table 39. South America Biological Sample Cryopreservation Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
- Table 40. South America Biological Sample Cryopreservation Market Size by Country (2021-2026) & (US$ Million)
- Table 41. South America Biological Sample Cryopreservation Market Size by Country (2027-2032) & (US$ Million)
- Table 42. Middle East & Africa Biological Sample Cryopreservation Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
- Table 43. Middle East & Africa Biological Sample Cryopreservation Market Size by Country (2021-2026) & (US$ Million)
- Table 44. Middle East & Africa Biological Sample Cryopreservation Market Size by Country (2027-2032) & (US$ Million)
- Table 45. Thermo Fisher Scientific Company Information
- Table 46. Thermo Fisher Scientific Business Overview
- Table 47. Thermo Fisher Scientific Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 48. Thermo Fisher Scientific Biological Sample Cryopreservation Product Portfolio
- Table 49. Thermo Fisher Scientific Recent Developments
- Table 50. Haier Biomedical Company Information
- Table 51. Haier Biomedical Business Overview
- Table 52. Haier Biomedical Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 53. Haier Biomedical Biological Sample Cryopreservation Product Portfolio
- Table 54. Haier Biomedical Recent Developments
- Table 55. PHCbi Company Information
- Table 56. PHCbi Business Overview
- Table 57. PHCbi Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 58. PHCbi Biological Sample Cryopreservation Product Portfolio
- Table 59. PHCbi Recent Developments
- Table 60. Repligen Company Information
- Table 61. Repligen Business Overview
- Table 62. Repligen Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 63. Repligen Biological Sample Cryopreservation Product Portfolio
- Table 64. Repligen Recent Developments
- Table 65. Cryoport Company Information
- Table 66. Cryoport Business Overview
- Table 67. Cryoport Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 68. Cryoport Biological Sample Cryopreservation Product Portfolio
- Table 69. Cryoport Recent Developments
- Table 70. Azenta Life Sciences Company Information
- Table 71. Azenta Life Sciences Business Overview
- Table 72. Azenta Life Sciences Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 73. Azenta Life Sciences Biological Sample Cryopreservation Product Portfolio
- Table 74. Azenta Life Sciences Recent Developments
- Table 75. Cytiva Company Information
- Table 76. Cytiva Business Overview
- Table 77. Cytiva Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 78. Cytiva Biological Sample Cryopreservation Product Portfolio
- Table 79. Cytiva Recent Developments
- Table 80. Sartorius Company Information
- Table 81. Sartorius Business Overview
- Table 82. Sartorius Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 83. Sartorius Biological Sample Cryopreservation Product Portfolio
- Table 84. Sartorius Recent Developments
- Table 85. FUJIFILM Biosciences Company Information
- Table 86. FUJIFILM Biosciences Business Overview
- Table 87. FUJIFILM Biosciences Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 88. FUJIFILM Biosciences Biological Sample Cryopreservation Product Portfolio
- Table 89. FUJIFILM Biosciences Recent Developments
- Table 90. Lonza Company Information
- Table 91. Lonza Business Overview
- Table 92. Lonza Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 93. Lonza Biological Sample Cryopreservation Product Portfolio
- Table 94. Lonza Recent Developments
- Table 95. Corning Company Information
- Table 96. Corning Business Overview
- Table 97. Corning Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 98. Corning Biological Sample Cryopreservation Product Portfolio
- Table 99. Corning Recent Developments
- Table 100. Eppendorf Company Information
- Table 101. Eppendorf Business Overview
- Table 102. Eppendorf Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 103. Eppendorf Biological Sample Cryopreservation Product Portfolio
- Table 104. Eppendorf Recent Developments
- Table 105. Greiner Company Information
- Table 106. Greiner Business Overview
- Table 107. Greiner Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 108. Greiner Biological Sample Cryopreservation Product Portfolio
- Table 109. Greiner Recent Developments
- Table 110. SARSTEDT Company Information
- Table 111. SARSTEDT Business Overview
- Table 112. SARSTEDT Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 113. SARSTEDT Biological Sample Cryopreservation Product Portfolio
- Table 114. SARSTEDT Recent Developments
- Table 115. Terumo Company Information
- Table 116. Terumo Business Overview
- Table 117. Terumo Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 118. Terumo Biological Sample Cryopreservation Product Portfolio
- Table 119. Terumo Recent Developments
- Table 120. CooperSurgical Company Information
- Table 121. CooperSurgical Business Overview
- Table 122. CooperSurgical Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 123. CooperSurgical Biological Sample Cryopreservation Product Portfolio
- Table 124. CooperSurgical Recent Developments
- Table 125. Vitrolife Company Information
- Table 126. Vitrolife Business Overview
- Table 127. Vitrolife Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 128. Vitrolife Biological Sample Cryopreservation Product Portfolio
- Table 129. Vitrolife Recent Developments
- Table 130. Nexpring Health Company Information
- Table 131. Nexpring Health Business Overview
- Table 132. Nexpring Health Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 133. Nexpring Health Biological Sample Cryopreservation Product Portfolio
- Table 134. Nexpring Health Recent Developments
- Table 135. Macopharma Company Information
- Table 136. Macopharma Business Overview
- Table 137. Macopharma Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 138. Macopharma Biological Sample Cryopreservation Product Portfolio
- Table 139. Macopharma Recent Developments
- Table 140. Miltenyi Biotec Company Information
- Table 141. Miltenyi Biotec Business Overview
- Table 142. Miltenyi Biotec Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 143. Miltenyi Biotec Biological Sample Cryopreservation Product Portfolio
- Table 144. Miltenyi Biotec Recent Developments
- Table 145. STEMCELL Technologies Company Information
- Table 146. STEMCELL Technologies Business Overview
- Table 147. STEMCELL Technologies Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 148. STEMCELL Technologies Biological Sample Cryopreservation Product Portfolio
- Table 149. STEMCELL Technologies Recent Developments
- Table 150. Kitazato Company Information
- Table 151. Kitazato Business Overview
- Table 152. Kitazato Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 153. Kitazato Biological Sample Cryopreservation Product Portfolio
- Table 154. Kitazato Recent Developments
- Table 155. Zhongke Meiling Cryogenics Company Information
- Table 156. Zhongke Meiling Cryogenics Business Overview
- Table 157. Zhongke Meiling Cryogenics Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 158. Zhongke Meiling Cryogenics Biological Sample Cryopreservation Product Portfolio
- Table 159. Zhongke Meiling Cryogenics Recent Developments
- Table 160. AUCMA Company Information
- Table 161. AUCMA Business Overview
- Table 162. AUCMA Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 163. AUCMA Biological Sample Cryopreservation Product Portfolio
- Table 164. AUCMA Recent Developments
- Table 165. BIOBASE Company Information
- Table 166. BIOBASE Business Overview
- Table 167. BIOBASE Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 168. BIOBASE Biological Sample Cryopreservation Product Portfolio
- Table 169. BIOBASE Recent Developments
- Table 170. Genepoint Technologies Company Information
- Table 171. Genepoint Technologies Business Overview
- Table 172. Genepoint Technologies Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 173. Genepoint Technologies Biological Sample Cryopreservation Product Portfolio
- Table 174. Genepoint Technologies Recent Developments
- Table 175. Origincell Biological Cryo Equipment Company Information
- Table 176. Origincell Biological Cryo Equipment Business Overview
- Table 177. Origincell Biological Cryo Equipment Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 178. Origincell Biological Cryo Equipment Biological Sample Cryopreservation Product Portfolio
- Table 179. Origincell Biological Cryo Equipment Recent Developments
- Table 180. Basecare Medical Company Information
- Table 181. Basecare Medical Business Overview
- Table 182. Basecare Medical Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 183. Basecare Medical Biological Sample Cryopreservation Product Portfolio
- Table 184. Basecare Medical Recent Developments
- Table 185. Hamilton Company Company Information
- Table 186. Hamilton Company Business Overview
- Table 187. Hamilton Company Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 188. Hamilton Company Biological Sample Cryopreservation Product Portfolio
- Table 189. Hamilton Company Recent Developments
- Table 190. LiCONiC Company Information
- Table 191. LiCONiC Business Overview
- Table 192. LiCONiC Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 193. LiCONiC Biological Sample Cryopreservation Product Portfolio
- Table 194. LiCONiC Recent Developments
- Table 195. ASKION Company Information
- Table 196. ASKION Business Overview
- Table 197. ASKION Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 198. ASKION Biological Sample Cryopreservation Product Portfolio
- Table 199. ASKION Recent Developments
- Table 200. SPT Labtech Company Information
- Table 201. SPT Labtech Business Overview
- Table 202. SPT Labtech Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 203. SPT Labtech Biological Sample Cryopreservation Product Portfolio
- Table 204. SPT Labtech Recent Developments
- Table 205. B Medical Systems Company Information
- Table 206. B Medical Systems Business Overview
- Table 207. B Medical Systems Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 208. B Medical Systems Biological Sample Cryopreservation Product Portfolio
- Table 209. B Medical Systems Recent Developments
- Table 210. Custom Biogenic Systems Company Information
- Table 211. Custom Biogenic Systems Business Overview
- Table 212. Custom Biogenic Systems Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 213. Custom Biogenic Systems Biological Sample Cryopreservation Product Portfolio
- Table 214. Custom Biogenic Systems Recent Developments
- Table 215. IC Biomedical Company Information
- Table 216. IC Biomedical Business Overview
- Table 217. IC Biomedical Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 218. IC Biomedical Biological Sample Cryopreservation Product Portfolio
- Table 219. IC Biomedical Recent Developments
- Table 220. Cryo Bio System Company Information
- Table 221. Cryo Bio System Business Overview
- Table 222. Cryo Bio System Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 223. Cryo Bio System Biological Sample Cryopreservation Product Portfolio
- Table 224. Cryo Bio System Recent Developments
- Table 225. Stirling Ultracold Company Information
- Table 226. Stirling Ultracold Business Overview
- Table 227. Stirling Ultracold Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 228. Stirling Ultracold Biological Sample Cryopreservation Product Portfolio
- Table 229. Stirling Ultracold Recent Developments
- Table 230. Helmer Scientific Company Information
- Table 231. Helmer Scientific Business Overview
- Table 232. Helmer Scientific Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 233. Helmer Scientific Biological Sample Cryopreservation Product Portfolio
- Table 234. Helmer Scientific Recent Developments
- Table 235. Micronic Company Information
- Table 236. Micronic Business Overview
- Table 237. Micronic Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 238. Micronic Biological Sample Cryopreservation Product Portfolio
- Table 239. Micronic Recent Developments
- Table 240. OriGen Biomedical Company Information
- Table 241. OriGen Biomedical Business Overview
- Table 242. OriGen Biomedical Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 243. OriGen Biomedical Biological Sample Cryopreservation Product Portfolio
- Table 244. OriGen Biomedical Recent Developments
- Table 245. BINDER Company Information
- Table 246. BINDER Business Overview
- Table 247. BINDER Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 248. BINDER Biological Sample Cryopreservation Product Portfolio
- Table 249. BINDER Recent Developments
- Table 250. Liebherr Company Information
- Table 251. Liebherr Business Overview
- Table 252. Liebherr Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 253. Liebherr Biological Sample Cryopreservation Product Portfolio
- Table 254. Liebherr Recent Developments
- Table 255. Esco Lifesciences Company Information
- Table 256. Esco Lifesciences Business Overview
- Table 257. Esco Lifesciences Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 258. Esco Lifesciences Biological Sample Cryopreservation Product Portfolio
- Table 259. Esco Lifesciences Recent Developments
- Table 260. Cryopal Company Information
- Table 261. Cryopal Business Overview
- Table 262. Cryopal Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 263. Cryopal Biological Sample Cryopreservation Product Portfolio
- Table 264. Cryopal Recent Developments
- Table 265. Cryotherm Company Information
- Table 266. Cryotherm Business Overview
- Table 267. Cryotherm Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 268. Cryotherm Biological Sample Cryopreservation Product Portfolio
- Table 269. Cryotherm Recent Developments
- Table 270. Cryo Diffusion Company Information
- Table 271. Cryo Diffusion Business Overview
- Table 272. Cryo Diffusion Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 273. Cryo Diffusion Biological Sample Cryopreservation Product Portfolio
- Table 274. Cryo Diffusion Recent Developments
- Table 275. Statebourne Cryogenics Company Information
- Table 276. Statebourne Cryogenics Business Overview
- Table 277. Statebourne Cryogenics Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 278. Statebourne Cryogenics Biological Sample Cryopreservation Product Portfolio
- Table 279. Statebourne Cryogenics Recent Developments
- Table 280. Celltrio Company Information
- Table 281. Celltrio Business Overview
- Table 282. Celltrio Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 283. Celltrio Biological Sample Cryopreservation Product Portfolio
- Table 284. Celltrio Recent Developments
- Table 285. ThermoGenesis Company Information
- Table 286. ThermoGenesis Business Overview
- Table 287. ThermoGenesis Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 288. ThermoGenesis Biological Sample Cryopreservation Product Portfolio
- Table 289. ThermoGenesis Recent Developments
- Table 290. Jiangsu SERLNG Company Information
- Table 291. Jiangsu SERLNG Business Overview
- Table 292. Jiangsu SERLNG Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 293. Jiangsu SERLNG Biological Sample Cryopreservation Product Portfolio
- Table 294. Jiangsu SERLNG Recent Developments
- Table 295. SYLAB Company Information
- Table 296. SYLAB Business Overview
- Table 297. SYLAB Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 298. SYLAB Biological Sample Cryopreservation Product Portfolio
- Table 299. SYLAB Recent Developments
- Table 300. Consarctic Company Information
- Table 301. Consarctic Business Overview
- Table 302. Consarctic Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 303. Consarctic Biological Sample Cryopreservation Product Portfolio
- Table 304. Consarctic Recent Developments
- Table 305. PromoCell Company Information
- Table 306. PromoCell Business Overview
- Table 307. PromoCell Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 308. PromoCell Biological Sample Cryopreservation Product Portfolio
- Table 309. PromoCell Recent Developments
- Table 310. FertiPro Company Information
- Table 311. FertiPro Business Overview
- Table 312. FertiPro Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 313. FertiPro Biological Sample Cryopreservation Product Portfolio
- Table 314. FertiPro Recent Developments
- Table 315. CryoLogic Company Information
- Table 316. CryoLogic Business Overview
- Table 317. CryoLogic Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 318. CryoLogic Biological Sample Cryopreservation Product Portfolio
- Table 319. CryoLogic Recent Developments
- Table 320. Cryofab Company Information
- Table 321. Cryofab Business Overview
- Table 322. Cryofab Revenue in Biological Sample Cryopreservation Business (2021-2026) & (US$ Million)
- Table 323. Cryofab Biological Sample Cryopreservation Product Portfolio
- Table 324. Cryofab Recent Developments
- Table 325. Authors List of This Report
List of Figures
- Figure 1. Research Methodology
- Figure 2. Research Process
- Figure 3. Key Executives Interviewed
- Figure 4. Biological Sample Cryopreservation Product Image
- Figure 5. Global Biological Sample Cryopreservation Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- Figure 6. Global Biological Sample Cryopreservation Market Share by Type: 2025 VS 2032
- Figure 7. Cryopreservation Equipment Product
- Figure 8. Cryopreservation Media & Reagents Product
- Figure 9. Cryopreservation Containers & Accessories Product
- Figure 10. Cryopreservation Services Product
- Figure 11. Global Biological Sample Cryopreservation Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
- Figure 12. Global Biological Sample Cryopreservation Market Share by Application: 2025 VS 2032
- Figure 13. Biobanking Product
- Figure 14. Biomedical Research Product
- Figure 15. Biopharmaceutical Manufacturing Product
- Figure 16. Cell & Gene Therapy Product
- Figure 17. Assisted Reproduction Product
- Figure 18. Clinical Diagnostics Product
- Figure 19. Animal Breeding Product
- Figure 20. Global Biological Sample Cryopreservation Market Size (US$ Million), Year-over-Year: 2021-2032
- Figure 21. Global Biological Sample Cryopreservation Market Size, (US$ Million), 2021 VS 2025 VS 2032
- Figure 22. Global Biological Sample Cryopreservation Market Share by Region: 2025 VS 2032
- Figure 23. Global Biological Sample Cryopreservation Market Share by Players in 2025
- Figure 24. Global Biological Sample Cryopreservation Manufacturers Established Date
- Figure 25. Global Top 5 and 10 Biological Sample Cryopreservation Players Market Share by Revenue in 2025
- Figure 26. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
- Figure 27. North America Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 28. North America Biological Sample Cryopreservation Market Share by Country (2021-2032)
- Figure 29. United States Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 30. Canada Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 31. Mexico Biological Sample Cryopreservation Market Share by Country (2021-2032)
- Figure 32. Europe Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 33. Europe Biological Sample Cryopreservation Market Share by Country (2021-2032)
- Figure 34. Germany Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 35. France Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 36. U.K. Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 37. Italy Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 38. Spain Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 39. Russia Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 40. Netherlands Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 41. Nordic Countries Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 42. Asia-Pacific Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 43. Asia-Pacific Biological Sample Cryopreservation Market Share by Country (2021-2032)
- Figure 44. China Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 45. Japan Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 46. South Korea Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 47. India Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 48. India Biological Sample Cryopreservation Market Share by Country (2021-2032)
- Figure 49. Australia Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 50. China Taiwan Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 51. Southeast Asia Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 52. South America Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 53. South America Biological Sample Cryopreservation Market Share by Country (2021-2032)
- Figure 54. Brazil Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 55. Argentina Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 56. Chile Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 57. Colombia Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 58. Peru Biological Sample Cryopreservation Market Size YoY Growth (2021-2032) & (US$ Million)
- Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 60. Haier Biomedical Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 61. PHCbi Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 62. Repligen Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 63. Cryoport Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 64. Azenta Life Sciences Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 65. Cytiva Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 66. Sartorius Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 67. FUJIFILM Biosciences Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 68. Lonza Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 69. Corning Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 70. Eppendorf Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 71. Greiner Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 72. SARSTEDT Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 73. Terumo Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 74. CooperSurgical Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 75. Vitrolife Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 76. Nexpring Health Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 77. Macopharma Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 78. Miltenyi Biotec Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 79. STEMCELL Technologies Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 80. Kitazato Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 81. Zhongke Meiling Cryogenics Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 82. AUCMA Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 83. BIOBASE Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 84. Genepoint Technologies Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 85. Origincell Biological Cryo Equipment Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 86. Basecare Medical Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 87. Hamilton Company Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 88. LiCONiC Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 89. ASKION Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 90. SPT Labtech Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 91. B Medical Systems Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 92. Custom Biogenic Systems Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 93. IC Biomedical Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 94. Cryo Bio System Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 95. Stirling Ultracold Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 96. Helmer Scientific Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 97. Micronic Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 98. OriGen Biomedical Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 99. BINDER Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 100. Liebherr Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 101. Esco Lifesciences Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 102. Cryopal Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 103. Cryotherm Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 104. Cryo Diffusion Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 105. Statebourne Cryogenics Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 106. Celltrio Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 107. ThermoGenesis Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 108. Jiangsu SERLNG Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 109. SYLAB Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 110. Consarctic Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 111. PromoCell Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 112. FertiPro Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 113. CryoLogic Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
- Figure 114. Cryofab Revenue Growth Rate in Biological Sample Cryopreservation Business (2021-2026)
Scope & coverage.
By Type
- Cryopreservation Equipment
- Cryopreservation Media & Reagents
- Cryopreservation Containers & Accessories
- Cryopreservation Services
By Application
- Biobanking
- Biomedical Research
- Biopharmaceutical Manufacturing
- Cell & Gene Therapy
- Assisted Reproduction
- Clinical Diagnostics
- Animal Breeding
Companies covered
- Thermo Fisher Scientific
- Haier Biomedical
- PHCbi
- Repligen
- Cryoport
- Azenta Life Sciences
- Cytiva
- Sartorius
- FUJIFILM Biosciences
- Lonza
- Corning
- Eppendorf
- Greiner
- SARSTEDT
- Terumo
- CooperSurgical
- Vitrolife
- Nexpring Health
- Macopharma
- Miltenyi Biotec
- STEMCELL Technologies
- Kitazato
- Zhongke Meiling Cryogenics
- AUCMA
- BIOBASE
- Genepoint Technologies
- Origincell Biological Cryo Equipment
- Basecare Medical
- Hamilton Company
- LiCONiC
- ASKION
- SPT Labtech
- B Medical Systems
- Custom Biogenic Systems
- IC Biomedical
- Cryo Bio System
- Stirling Ultracold
- Helmer Scientific
- Micronic
- OriGen Biomedical
- BINDER
- Liebherr
- Esco Lifesciences
- Cryopal
- Cryotherm
- Cryo Diffusion
- Statebourne Cryogenics
- Celltrio
- ThermoGenesis
- Jiangsu SERLNG
- SYLAB
- Consarctic
- PromoCell
- FertiPro
- CryoLogic
- Cryofab
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biological Sample Cryopreservation by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cryopreservation Equipment
- 2.2.3 Cryopreservation Media & Reagents
- 2.2.4 Cryopreservation Containers & Accessories
- 2.2.5 Cryopreservation Services
- 2.3 Biological Sample Cryopreservation by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biobanking
- 2.3.3 Biomedical Research
- 2.3.4 Biopharmaceutical Manufacturing
- 2.3.5 Cell & Gene Therapy
- 2.3.6 Assisted Reproduction
- 2.3.7 Clinical Diagnostics
- 2.3.8 Animal Breeding
- 2.4 Assumptions and Limitations
3 Biological Sample Cryopreservation Breakdown Data by Type
- 3.1 Global Biological Sample Cryopreservation Historic Market Size by Type (2021-2026)
- 3.2 Global Biological Sample Cryopreservation Forecasted Market Size by Type (2027-2032)
4 Biological Sample Cryopreservation Breakdown Data by Application
- 4.1 Global Biological Sample Cryopreservation Historic Market Size by Application (2021-2026)
- 4.2 Global Biological Sample Cryopreservation Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biological Sample Cryopreservation Market Perspective (2021-2032)
- 5.2 Global Biological Sample Cryopreservation Growth Trends by Region
- 5.2.1 Global Biological Sample Cryopreservation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biological Sample Cryopreservation Historic Market Size by Region (2021-2026)
- 5.2.3 Biological Sample Cryopreservation Forecasted Market Size by Region (2027-2032)
- 5.3 Biological Sample Cryopreservation Market Dynamics
- 5.3.1 Biological Sample Cryopreservation Industry Trends
- 5.3.2 Biological Sample Cryopreservation Market Drivers
- 5.3.3 Biological Sample Cryopreservation Market Challenges
- 5.3.4 Biological Sample Cryopreservation Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biological Sample Cryopreservation Players by Revenue
- 6.1.1 Global Top Biological Sample Cryopreservation Players by Revenue (2021-2026)
- 6.1.2 Global Biological Sample Cryopreservation Revenue Market Share by Players (2021-2026)
- 6.2 Global Biological Sample Cryopreservation Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biological Sample Cryopreservation Head Office and Area Served
- 6.4 Global Biological Sample Cryopreservation Players, Product Type & Application
- 6.5 Global Biological Sample Cryopreservation Manufacturers Established Date
- 6.6 Global Biological Sample Cryopreservation Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biological Sample Cryopreservation Market Size (2021-2032)
- 7.2 North America Biological Sample Cryopreservation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biological Sample Cryopreservation Market Size by Country (2021-2026)
- 7.4 North America Biological Sample Cryopreservation Market Size by Country (2027-2032)
- 7.5 United States
- 7.6 United States
- 7.7 Canada
- 7.8 Mexico
8 Europe
- 8.1 Europe Biological Sample Cryopreservation Market Size (2021-2032)
- 8.2 Europe Biological Sample Cryopreservation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biological Sample Cryopreservation Market Size by Country (2021-2026)
- 8.4 Europe Biological Sample Cryopreservation Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biological Sample Cryopreservation Market Size (2021-2032)
- 9.2 Asia-Pacific Biological Sample Cryopreservation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biological Sample Cryopreservation Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biological Sample Cryopreservation Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biological Sample Cryopreservation Market Size (2021-2032)
- 10.2 South America Biological Sample Cryopreservation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biological Sample Cryopreservation Market Size by Country (2021-2026)
- 10.4 South America Biological Sample Cryopreservation Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biological Sample Cryopreservation Market Size (2021-2032)
- 11.2 Middle East & Africa Biological Sample Cryopreservation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biological Sample Cryopreservation Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biological Sample Cryopreservation Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Biological Sample Cryopreservation Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 Haier Biomedical
- 12.2.1 Haier Biomedical Company Information
- 12.2.2 Haier Biomedical Business Overview
- 12.2.3 Haier Biomedical Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.2.4 Haier Biomedical Biological Sample Cryopreservation Product Portfolio
- 12.2.5 Haier Biomedical Recent Developments
- 12.3 PHCbi
- 12.3.1 PHCbi Company Information
- 12.3.2 PHCbi Business Overview
- 12.3.3 PHCbi Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.3.4 PHCbi Biological Sample Cryopreservation Product Portfolio
- 12.3.5 PHCbi Recent Developments
- 12.4 Repligen
- 12.4.1 Repligen Company Information
- 12.4.2 Repligen Business Overview
- 12.4.3 Repligen Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.4.4 Repligen Biological Sample Cryopreservation Product Portfolio
- 12.4.5 Repligen Recent Developments
- 12.5 Cryoport
- 12.5.1 Cryoport Company Information
- 12.5.2 Cryoport Business Overview
- 12.5.3 Cryoport Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.5.4 Cryoport Biological Sample Cryopreservation Product Portfolio
- 12.5.5 Cryoport Recent Developments
- 12.6 Azenta Life Sciences
- 12.6.1 Azenta Life Sciences Company Information
- 12.6.2 Azenta Life Sciences Business Overview
- 12.6.3 Azenta Life Sciences Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.6.4 Azenta Life Sciences Biological Sample Cryopreservation Product Portfolio
- 12.6.5 Azenta Life Sciences Recent Developments
- 12.7 Cytiva
- 12.7.1 Cytiva Company Information
- 12.7.2 Cytiva Business Overview
- 12.7.3 Cytiva Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.7.4 Cytiva Biological Sample Cryopreservation Product Portfolio
- 12.7.5 Cytiva Recent Developments
- 12.8 Sartorius
- 12.8.1 Sartorius Company Information
- 12.8.2 Sartorius Business Overview
- 12.8.3 Sartorius Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.8.4 Sartorius Biological Sample Cryopreservation Product Portfolio
- 12.8.5 Sartorius Recent Developments
- 12.9 FUJIFILM Biosciences
- 12.9.1 FUJIFILM Biosciences Company Information
- 12.9.2 FUJIFILM Biosciences Business Overview
- 12.9.3 FUJIFILM Biosciences Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.9.4 FUJIFILM Biosciences Biological Sample Cryopreservation Product Portfolio
- 12.9.5 FUJIFILM Biosciences Recent Developments
- 12.10 Lonza
- 12.10.1 Lonza Company Information
- 12.10.2 Lonza Business Overview
- 12.10.3 Lonza Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.10.4 Lonza Biological Sample Cryopreservation Product Portfolio
- 12.10.5 Lonza Recent Developments
- 12.11 Corning
- 12.11.1 Corning Company Information
- 12.11.2 Corning Business Overview
- 12.11.3 Corning Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.11.4 Corning Biological Sample Cryopreservation Product Portfolio
- 12.11.5 Corning Recent Developments
- 12.12 Eppendorf
- 12.12.1 Eppendorf Company Information
- 12.12.2 Eppendorf Business Overview
- 12.12.3 Eppendorf Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.12.4 Eppendorf Biological Sample Cryopreservation Product Portfolio
- 12.12.5 Eppendorf Recent Developments
- 12.13 Greiner
- 12.13.1 Greiner Company Information
- 12.13.2 Greiner Business Overview
- 12.13.3 Greiner Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.13.4 Greiner Biological Sample Cryopreservation Product Portfolio
- 12.13.5 Greiner Recent Developments
- 12.14 SARSTEDT
- 12.14.1 SARSTEDT Company Information
- 12.14.2 SARSTEDT Business Overview
- 12.14.3 SARSTEDT Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.14.4 SARSTEDT Biological Sample Cryopreservation Product Portfolio
- 12.14.5 SARSTEDT Recent Developments
- 12.15 Terumo
- 12.15.1 Terumo Company Information
- 12.15.2 Terumo Business Overview
- 12.15.3 Terumo Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.15.4 Terumo Biological Sample Cryopreservation Product Portfolio
- 12.15.5 Terumo Recent Developments
- 12.16 CooperSurgical
- 12.16.1 CooperSurgical Company Information
- 12.16.2 CooperSurgical Business Overview
- 12.16.3 CooperSurgical Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.16.4 CooperSurgical Biological Sample Cryopreservation Product Portfolio
- 12.16.5 CooperSurgical Recent Developments
- 12.17 Vitrolife
- 12.17.1 Vitrolife Company Information
- 12.17.2 Vitrolife Business Overview
- 12.17.3 Vitrolife Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.17.4 Vitrolife Biological Sample Cryopreservation Product Portfolio
- 12.17.5 Vitrolife Recent Developments
- 12.18 Nexpring Health
- 12.18.1 Nexpring Health Company Information
- 12.18.2 Nexpring Health Business Overview
- 12.18.3 Nexpring Health Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.18.4 Nexpring Health Biological Sample Cryopreservation Product Portfolio
- 12.18.5 Nexpring Health Recent Developments
- 12.19 Macopharma
- 12.19.1 Macopharma Company Information
- 12.19.2 Macopharma Business Overview
- 12.19.3 Macopharma Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.19.4 Macopharma Biological Sample Cryopreservation Product Portfolio
- 12.19.5 Macopharma Recent Developments
- 12.20 Miltenyi Biotec
- 12.20.1 Miltenyi Biotec Company Information
- 12.20.2 Miltenyi Biotec Business Overview
- 12.20.3 Miltenyi Biotec Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.20.4 Miltenyi Biotec Biological Sample Cryopreservation Product Portfolio
- 12.20.5 Miltenyi Biotec Recent Developments
- 12.21 STEMCELL Technologies
- 12.21.1 STEMCELL Technologies Company Information
- 12.21.2 STEMCELL Technologies Business Overview
- 12.21.3 STEMCELL Technologies Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.21.4 STEMCELL Technologies Biological Sample Cryopreservation Product Portfolio
- 12.21.5 STEMCELL Technologies Recent Developments
- 12.22 Kitazato
- 12.22.1 Kitazato Company Information
- 12.22.2 Kitazato Business Overview
- 12.22.3 Kitazato Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.22.4 Kitazato Biological Sample Cryopreservation Product Portfolio
- 12.22.5 Kitazato Recent Developments
- 12.23 Zhongke Meiling Cryogenics
- 12.23.1 Zhongke Meiling Cryogenics Company Information
- 12.23.2 Zhongke Meiling Cryogenics Business Overview
- 12.23.3 Zhongke Meiling Cryogenics Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.23.4 Zhongke Meiling Cryogenics Biological Sample Cryopreservation Product Portfolio
- 12.23.5 Zhongke Meiling Cryogenics Recent Developments
- 12.24 AUCMA
- 12.24.1 AUCMA Company Information
- 12.24.2 AUCMA Business Overview
- 12.24.3 AUCMA Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.24.4 AUCMA Biological Sample Cryopreservation Product Portfolio
- 12.24.5 AUCMA Recent Developments
- 12.25 BIOBASE
- 12.25.1 BIOBASE Company Information
- 12.25.2 BIOBASE Business Overview
- 12.25.3 BIOBASE Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.25.4 BIOBASE Biological Sample Cryopreservation Product Portfolio
- 12.25.5 BIOBASE Recent Developments
- 12.26 Genepoint Technologies
- 12.26.1 Genepoint Technologies Company Information
- 12.26.2 Genepoint Technologies Business Overview
- 12.26.3 Genepoint Technologies Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.26.4 Genepoint Technologies Biological Sample Cryopreservation Product Portfolio
- 12.26.5 Genepoint Technologies Recent Developments
- 12.27 Origincell Biological Cryo Equipment
- 12.27.1 Origincell Biological Cryo Equipment Company Information
- 12.27.2 Origincell Biological Cryo Equipment Business Overview
- 12.27.3 Origincell Biological Cryo Equipment Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.27.4 Origincell Biological Cryo Equipment Biological Sample Cryopreservation Product Portfolio
- 12.27.5 Origincell Biological Cryo Equipment Recent Developments
- 12.28 Basecare Medical
- 12.28.1 Basecare Medical Company Information
- 12.28.2 Basecare Medical Business Overview
- 12.28.3 Basecare Medical Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.28.4 Basecare Medical Biological Sample Cryopreservation Product Portfolio
- 12.28.5 Basecare Medical Recent Developments
- 12.29 Hamilton Company
- 12.29.1 Hamilton Company Company Information
- 12.29.2 Hamilton Company Business Overview
- 12.29.3 Hamilton Company Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.29.4 Hamilton Company Biological Sample Cryopreservation Product Portfolio
- 12.29.5 Hamilton Company Recent Developments
- 12.30 LiCONiC
- 12.30.1 LiCONiC Company Information
- 12.30.2 LiCONiC Business Overview
- 12.30.3 LiCONiC Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.30.4 LiCONiC Biological Sample Cryopreservation Product Portfolio
- 12.30.5 LiCONiC Recent Developments
- 12.31 ASKION
- 12.31.1 ASKION Company Information
- 12.31.2 ASKION Business Overview
- 12.31.3 ASKION Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.31.4 ASKION Biological Sample Cryopreservation Product Portfolio
- 12.31.5 ASKION Recent Developments
- 12.32 SPT Labtech
- 12.32.1 SPT Labtech Company Information
- 12.32.2 SPT Labtech Business Overview
- 12.32.3 SPT Labtech Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.32.4 SPT Labtech Biological Sample Cryopreservation Product Portfolio
- 12.32.5 SPT Labtech Recent Developments
- 12.33 B Medical Systems
- 12.33.1 B Medical Systems Company Information
- 12.33.2 B Medical Systems Business Overview
- 12.33.3 B Medical Systems Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.33.4 B Medical Systems Biological Sample Cryopreservation Product Portfolio
- 12.33.5 B Medical Systems Recent Developments
- 12.34 Custom Biogenic Systems
- 12.34.1 Custom Biogenic Systems Company Information
- 12.34.2 Custom Biogenic Systems Business Overview
- 12.34.3 Custom Biogenic Systems Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.34.4 Custom Biogenic Systems Biological Sample Cryopreservation Product Portfolio
- 12.34.5 Custom Biogenic Systems Recent Developments
- 12.35 IC Biomedical
- 12.35.1 IC Biomedical Company Information
- 12.35.2 IC Biomedical Business Overview
- 12.35.3 IC Biomedical Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.35.4 IC Biomedical Biological Sample Cryopreservation Product Portfolio
- 12.35.5 IC Biomedical Recent Developments
- 12.36 Cryo Bio System
- 12.36.1 Cryo Bio System Company Information
- 12.36.2 Cryo Bio System Business Overview
- 12.36.3 Cryo Bio System Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.36.4 Cryo Bio System Biological Sample Cryopreservation Product Portfolio
- 12.36.5 Cryo Bio System Recent Developments
- 12.37 Stirling Ultracold
- 12.37.1 Stirling Ultracold Company Information
- 12.37.2 Stirling Ultracold Business Overview
- 12.37.3 Stirling Ultracold Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.37.4 Stirling Ultracold Biological Sample Cryopreservation Product Portfolio
- 12.37.5 Stirling Ultracold Recent Developments
- 12.38 Helmer Scientific
- 12.38.1 Helmer Scientific Company Information
- 12.38.2 Helmer Scientific Business Overview
- 12.38.3 Helmer Scientific Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.38.4 Helmer Scientific Biological Sample Cryopreservation Product Portfolio
- 12.38.5 Helmer Scientific Recent Developments
- 12.39 Micronic
- 12.39.1 Micronic Company Information
- 12.39.2 Micronic Business Overview
- 12.39.3 Micronic Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.39.4 Micronic Biological Sample Cryopreservation Product Portfolio
- 12.39.5 Micronic Recent Developments
- 12.40 OriGen Biomedical
- 12.40.1 OriGen Biomedical Company Information
- 12.40.2 OriGen Biomedical Business Overview
- 12.40.3 OriGen Biomedical Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.40.4 OriGen Biomedical Biological Sample Cryopreservation Product Portfolio
- 12.40.5 OriGen Biomedical Recent Developments
- 12.41 BINDER
- 12.41.1 BINDER Company Information
- 12.41.2 BINDER Business Overview
- 12.41.3 BINDER Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.41.4 BINDER Biological Sample Cryopreservation Product Portfolio
- 12.41.5 BINDER Recent Developments
- 12.42 Liebherr
- 12.42.1 Liebherr Company Information
- 12.42.2 Liebherr Business Overview
- 12.42.3 Liebherr Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.42.4 Liebherr Biological Sample Cryopreservation Product Portfolio
- 12.42.5 Liebherr Recent Developments
- 12.43 Esco Lifesciences
- 12.43.1 Esco Lifesciences Company Information
- 12.43.2 Esco Lifesciences Business Overview
- 12.43.3 Esco Lifesciences Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.43.4 Esco Lifesciences Biological Sample Cryopreservation Product Portfolio
- 12.43.5 Esco Lifesciences Recent Developments
- 12.44 Cryopal
- 12.44.1 Cryopal Company Information
- 12.44.2 Cryopal Business Overview
- 12.44.3 Cryopal Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.44.4 Cryopal Biological Sample Cryopreservation Product Portfolio
- 12.44.5 Cryopal Recent Developments
- 12.45 Cryotherm
- 12.45.1 Cryotherm Company Information
- 12.45.2 Cryotherm Business Overview
- 12.45.3 Cryotherm Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.45.4 Cryotherm Biological Sample Cryopreservation Product Portfolio
- 12.45.5 Cryotherm Recent Developments
- 12.46 Cryo Diffusion
- 12.46.1 Cryo Diffusion Company Information
- 12.46.2 Cryo Diffusion Business Overview
- 12.46.3 Cryo Diffusion Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.46.4 Cryo Diffusion Biological Sample Cryopreservation Product Portfolio
- 12.46.5 Cryo Diffusion Recent Developments
- 12.47 Statebourne Cryogenics
- 12.47.1 Statebourne Cryogenics Company Information
- 12.47.2 Statebourne Cryogenics Business Overview
- 12.47.3 Statebourne Cryogenics Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.47.4 Statebourne Cryogenics Biological Sample Cryopreservation Product Portfolio
- 12.47.5 Statebourne Cryogenics Recent Developments
- 12.48 Celltrio
- 12.48.1 Celltrio Company Information
- 12.48.2 Celltrio Business Overview
- 12.48.3 Celltrio Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.48.4 Celltrio Biological Sample Cryopreservation Product Portfolio
- 12.48.5 Celltrio Recent Developments
- 12.49 ThermoGenesis
- 12.49.1 ThermoGenesis Company Information
- 12.49.2 ThermoGenesis Business Overview
- 12.49.3 ThermoGenesis Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.49.4 ThermoGenesis Biological Sample Cryopreservation Product Portfolio
- 12.49.5 ThermoGenesis Recent Developments
- 12.50 Jiangsu SERLNG
- 12.50.1 Jiangsu SERLNG Company Information
- 12.50.2 Jiangsu SERLNG Business Overview
- 12.50.3 Jiangsu SERLNG Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.50.4 Jiangsu SERLNG Biological Sample Cryopreservation Product Portfolio
- 12.50.5 Jiangsu SERLNG Recent Developments
- 12.51 SYLAB
- 12.51.1 SYLAB Company Information
- 12.51.2 SYLAB Business Overview
- 12.51.3 SYLAB Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.51.4 SYLAB Biological Sample Cryopreservation Product Portfolio
- 12.51.5 SYLAB Recent Developments
- 12.52 Consarctic
- 12.52.1 Consarctic Company Information
- 12.52.2 Consarctic Business Overview
- 12.52.3 Consarctic Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.52.4 Consarctic Biological Sample Cryopreservation Product Portfolio
- 12.52.5 Consarctic Recent Developments
- 12.53 PromoCell
- 12.53.1 PromoCell Company Information
- 12.53.2 PromoCell Business Overview
- 12.53.3 PromoCell Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.53.4 PromoCell Biological Sample Cryopreservation Product Portfolio
- 12.53.5 PromoCell Recent Developments
- 12.54 FertiPro
- 12.54.1 FertiPro Company Information
- 12.54.2 FertiPro Business Overview
- 12.54.3 FertiPro Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.54.4 FertiPro Biological Sample Cryopreservation Product Portfolio
- 12.54.5 FertiPro Recent Developments
- 12.55 CryoLogic
- 12.55.1 CryoLogic Company Information
- 12.55.2 CryoLogic Business Overview
- 12.55.3 CryoLogic Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.55.4 CryoLogic Biological Sample Cryopreservation Product Portfolio
- 12.55.5 CryoLogic Recent Developments
- 12.56 Cryofab
- 12.56.1 Cryofab Company Information
- 12.56.2 Cryofab Business Overview
- 12.56.3 Cryofab Revenue in Biological Sample Cryopreservation Business (2021-2026)
- 12.56.4 Cryofab Biological Sample Cryopreservation Product Portfolio
- 12.56.5 Cryofab Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst